Literature DB >> 11675145

Antiviral activity of NMSO3 against adenovirus in vitro.

H Kaneko1, K Kato, S Mori, S Shigeta.   

Abstract

NMSO3, a sulfated sialyl lipid, was evaluated for its efficacy against adenovirus (AdV) in vitro. The median effective concentration (50% effective concentration, EC(50)) of NMSO3 against replication of AdV type 2 (AdV2), type 4 (AdV4), type 8 (AdV8) and type 37 (AdV37) was 0.21-0.71 microg/ml in HEp-2 cells and 1.01-1.41 microg/ml in MKN-28 cells. The EC(50) values of NMSO3 were lower than those of HPMPC and ddC, which were also evaluated. NMSO3 exhibited minimal cytotoxicity against HEp-2 cells and MKN-28 cells, both for which the median cytotoxic concentration (50% cytotoxic concentration, CC(50)) was more than 1000 microg/ml. NMSO3 was the most potent and selective anti-AdV compound of those examined. NMSO3 inhibited AdV infection of HEp-2 cells only when present during the virus adsorption period. A virus binding assay using radiolabeled AdV4 revealed that NMSO3 inhibited viral binding to the HEp-2 cells. NMSO3 itself bound to the virus particles, but not to the HEp-2 cell membrane. Thus, the mechanism of anti-AdV activity by NMSO3 involves inhibition of virus adsorption to cells by NMSO3 binding to viral particles.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11675145     DOI: 10.1016/s0166-3542(01)00167-x

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  7 in total

1.  Anti-adenoviral effect of anti-HIV agents in vitro in serotypes inducing keratoconjunctivitis.

Authors:  Eiichi Uchio; Aki Fuchigami; Kazuaki Kadonosono; Akio Hayashi; Hiroaki Ishiko; Koki Aoki; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-17       Impact factor: 3.117

2.  Antiadenovirus activities of several classes of nucleoside and nucleotide analogues.

Authors:  L Naesens; L Lenaerts; G Andrei; R Snoeck; D Van Beers; Antonin Holy; Jan Balzarini; Erik De Clercq
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Development of liposomal nanoconstructs targeting P-selectin (CD62P)-expressing cells by using a sulfated derivative of sialic acid.

Authors:  Saotomo Itoh; Kumi Kawano; Kana Takeshita; Yoshie Maitani; Tsutomu Tsuji
Journal:  Pharm Res       Date:  2014-05-03       Impact factor: 4.200

4.  Protective efficacy of a sulfated sialyl lipid (NMSO3) against human rotavirus-induced diarrhea in a mouse model.

Authors:  Kazuo Takahashi; Kazutaka Ohashi; Yurika Abe; Shuichi Mori; Koki Taniguchi; Takusaburo Ebina; Osamu Nakagomi; Masaki Terada; Shiro Shigeta
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 5.  Targeting RSV with vaccines and small molecule drugs.

Authors:  Heather M Costello; William C Ray; Supranee Chaiwatpongsakorn; Mark E Peeples
Journal:  Infect Disord Drug Targets       Date:  2012-04

6.  Coexpression of hepatitis C virus E1 and E2 chimeric envelope glycoproteins displays separable ligand sensitivity and increases pseudotype infectious titer.

Authors:  Keith Meyer; Aster Beyene; Terry L Bowlin; Arnab Basu; Ranjit Ray
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

7.  Application of human lymphoid cells for the evaluation of antivirals against human adenovirus type 19: Zalcitabine has superior activity compared to cidofovir.

Authors:  Kohsuke Nakagawara; Hironori Hayashi; Kumi Kawaji; Mina Sasano; Eiichi N Kodama
Journal:  Antivir Chem Chemother       Date:  2020 Jan-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.